![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » OctoPlus and Biolex Announce Joint Development of Locteron
OctoPlus and Biolex Announce Joint Development of Locteron
OctoPlus, the drug delivery and development company and Biolex Inc., a protein therapeutics company, announced today that they have entered into collaboration for co-development of a controlled release formulation of recombinant human alfa interferon. The product, named Locteron, combines OctoPlus' proprietary biodegradable PolyActive drug delivery technology with Biolex' BLX-883, a recombinant alfa interferon produced in its proprietary LEX System.
Yahoo News (http://biz.yahoo.com/prnews/050216/ukw010_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct